As of November 2024, Allergy Therapeutics has a market cap of $38.05M. This makes Allergy Therapeutics the world's 15387th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $21.24M | -4.00% |
2023 | $22.12M | -60.00% |
2022 | $55.30M | -80.62% |
2021 | $285.37M | 93.98% |
2020 | $147.11M | 62.20% |
2019 | $90.70M | -24.77% |
2018 | $120.56M | -52.19% |
2017 | $252.19M | 36.53% |
2016 | $184.72M | -29.24% |
2015 | $261.04M | 20.41% |
2014 | $216.79M | 206.25% |
2013 | $70.79M | -29.67% |
2012 | $100.65M | 10.98% |
2011 | $90.70M | 26.15% |
2010 | $71.90M | -44.92% |
2009 | $130.52M | 40.48% |
2008 | $92.91M | -73.08% |
2007 | $345.10M | -60.00% |
2006 | $862.75M | 26.62% |
2005 | $681.35M | -16.30% |
2004 | $814.09M | - |